General Session 8:00 am – 9:30 am
|
G02
Diabetes During the Child-Bearing Years
Lois Jovanovic', MD, FACE
CEO & Chief Scientific Officer
Sansum Diabetes Research Institute; Santa Barbara, CA
Diabetes during the child-bearing years…it’s not just gestational diabetes anymore. Dr.
Jovanovic' will discuss a new issue – type 2 patients having babies. Evaluating and educating
patients of child-bearing years is a new and growing role for the diabetes educator.
UPN: 069-000-08-161-L01-P
Back to
Overview
|
Concurrent Breakout Sessions
10:30 am – 11:30 am
|
T01
Advanced Carbohydrate Counting: Conversing with the Experts - People with Diabetes
Hope Warshaw, MMSC, RD, BC-ADM, CDE
Owner
Hope Warshaw Associates, LLC; Alexandria, VA
Often, when educators look to learn about teaching a diabetes concept such as advanced
carbohydrate counting, they look to their fellow educators for advice. Yes, we need that didactic
training, but this session turns the tables by seeking out advice from those with a most valuable
perspective, people who have diabetes.
UPN: 069-000-08-045-L01-P
Back to
Overview
|
T02
Strategies for Primary and Secondary Prevention of Type 1 Diabetes
Jay Skyler, MD, MACP
Chairman
Diabetes Research Institute, University of Miami Miller School of Medicine; Miami, FL
Attend this session to hear more about recent T1D prevention studies that are well designed,
adequately powered, and carefully conducted.
UPN: 069-000-08-039-L04-P
Back to
Overview
|
T03
Providing Diabetes Intervention Services in an Automobile Assembly Plant
Roger P. Austin, MS, RPh, CDE
Clinical Pharmacist
Henry Ford Health System; Sterling Heights, MI
The working adult with diabetes has limited time to manage their disease, much less the time
to attend diabetes education programs. Hear how this type 2 worksite presents an excellent venue
for diabetes educators to interact with patients.
UPN: 069-000-08-072-L04-P
Back to
Overview
|
T04
Diabetes, Hypertension and Kidney Disease: An Update Through Cases
Condit F. Steil, PharmD, CDE, FAPhA
Associate Professor of Pharmacy Practice
Samford University; Birmingham, AL
This presentation will cover the care of chronic kidney disease (CKD) in diabetes. The
update will be provided through case presentations from a rural, community-based clinic service
that has a very high incidence of CKD, diabetes and hypertension.
UPN: 069-000-08-140-L01-P
Back to
Overview
|
T05
Understanding and Managing Hypoglycemia
Katie Weinger, EdD, RN
Investigator
Joslin Diabetes Center; Boston, MA
This symposium describes the physiology underlying the symptoms and cognitive changes
associated with hypoglycemia, its impact on relationships and patient safety, and clinical
strategies that are useful for preventing severe hypoglycemia.
UPN: 069-000-08-039-L04-P
Back to
Overview
|
T06
Getting to the Big Time… Take Your Idea to AADE
Virginia Valentine, BC-ADM, CNS, CDE
CEO
Diabetes Network, Inc.; Albuquerque, NM
Diabetes educators often identify strategies that improve diabetes education. Hear some great
ideas to share with colleagues at AADE if selected as an AADE session. This experienced presenter
will share the secrets to take your great idea to the big time.
UPN: 069-000-08-096-L04-P
Back to
Overview
|
T07
Insulin Pump Therapy in Pediatrics - Achieving Glycemic Control
Jean Corrigan, RN, MA, CDE
Program Director
Winthrop University Hospital; Mineola, NY
This lecture presents a wealth of information on insulin pump therapy in the pediatric
population. For the center looking to design a pediatric pump program, or for centers new to
pumping, this presentation will demonstrate the varied methods that have been successful.
UPN: 069-000-08-081-L01-P
Back to
Overview
|
T08
Change a Life in 30 Seconds: Smoking Cessation Tools
Deborah Greenwood, MEd, APRN, BC-ADM, CDE
Diabetes Nurse Educator/Clinical Nurse Specialist
Sutter Medical Foundation; Granite Bay, CA
Tami MacAller, MPH, CHES
Senior Health Promotion Specialist
California Diabetes Program; Sacramento, CA
National prevalence of smoking is decreasing, yet one in six people with diabetes still
smoke. The advice of a health care provider can double a person's chance of quitting especially
when referred to smoking cessation services. Help save lives - learn more!
UPN: 069-000-08-125-L04-P
Back to
Overview
|
T09
Prevention of Diabetes through School-Based Nutrition Interventions
Sheri Hotchkiss, RD, LD, CDE
Outpatient Dietitian
Frisbie Memorial Hospital; Rochester, NH
Ericka Pine, BS, RD, LD
Outpatient Dietitian
Frisbie Memorial Hospital; Rochester, NH
Diabetes and childhood obesity are growing problems in the United States. Prevention is
one way we can start to reverse this trend. In this session, learn how diabetes educators
have expanded their roles to provide school-based interventions.
UPN: 069-000-08-061-L01-P
Back to
Overview
|
T10
Motivational Interviewing: its Application in Multi-Center and Diverse Population Settings
Elaine Massaro, MS, RN, CDE
Clinical Nurse Specialist/Research Coordinator
Northwestern University Feinberg School of Medicine; Chicago, IL
Understanding multicultural variations and the unique cultural influences on behavior change
is a key ingredient in successful diabetes self-management education. Be sure to “sharpen the saw”
by attending this energizing session.
UPN: 069-000-08-068-L04-P
Back to
Overview
|
Concurrent Breakout Sessions
10:30 am – 12:00 pm
|
T11
Beyond DSME: Providing On-going Self-Management Support
Martha M. Funnell, RN, MS, CDE
Clinical Nurse Specialist
University of Michigan Medical School; Ann Arbor, MI
Bob Anderson, EdD
Professor
University of Michigan; Ann Arbor, MI
Kate Lorig, RN, DrPh
Professor
Stanford University; Palo Alto, CA
Athena Philis-Tsimikas, MD
Executive Director
The Whittier Institute for Diabetes; La Jolla, CA
The 2007 Standards for DSME require that on going support be arranged for patients at the
completion of DSME programs. This evidence-based concept is relatively new in diabetes education
and requires different programmatic and facilitation skills.
UPN: 069-000-08-127-L04-P
Back to
Overview
|
T12
The Art of the Argument
Christopher Parkin, MS
President
CGParkin Communications, Inc.; Carmel, IN
The Art of the Argument: Making Presentation Software Work for You is a fast-paced,
interactive program that explores key concepts and considerations relevant to the graphic and
content design of visual presentations.
UPN: 069-000-08-107-L04-P
Back to
Overview
|
T13
Primary Care, Populations and Educators: What You Need to Know
Jaan Sidorov, MD, MHSA
Principal
Sidorov Health Solutions; Harrisburg, PA
In this overview session, attendees will acquire a special insight about the changing face of
primary care and the ever increasing role of diabetes educators in assuring high quality diabetes
care.
UPN: 069-000-08-095-L04-P
Back to
Overview
|
T14
Ace Road Map To Achieving Glycemic Control in Type 2 Diabetes
Paul S. Jellinger, MD, MACE
Past President, American College of Endocrinology
American Association of Clinical Endocrinologists (AACE)
Professor of Medicine, Voluntary Faculty
University of Miami
The Center for Diabetes & Endocrine Care
Hollywood, FL
This session is designed to review the background leading to the development of the ACE/AACE
Diabetes Treatment Roadmaps and the principles on which the Roadmaps were developed. This useful
clinical tool emphasizes the need to control postprandial blood sugar, particularly at the lower
A1C's and stratifies treatment regimens based on current A1C, either in treatment naïve patients or
in patients on treatment who have failed to reach goal. Differences between this strategy for
glycemic control and the American Diabetes Association algorithm will be noted.
UPN: 069-000-08-182-L01-P
Back to
Overview
|
T15
Envisioning Better Inpatient Care: Developing a Diabetes Resource Nurse Program
Susan Hricko, RN, MSN, BC-ADM, CDE
Diabetes Education Coordinator
St. Luke's Episcopal Hospital; Houston, TX
Today's healthcare system is so dynamic that RN's are challenged to maintain knowledge and
skills needed for care of complex hospitalized patients with diabetes. This presentation will
describe development and expansion of a diabetes resources.
UPN: 069-000-08-055-L04-P
Back to
Overview
|
Concurrent Breakout Sessions 1:30 pm – 2:30 pm
|
T16
Science-Based Strategies in Weight Management (Overview)
Wahida Karmally, DrPH, RD, CDE, CLS
Associate Research Scientist, Director of Nutrition
Columbia University; New York, NY
Obesity in the U.S. and globally has increased markedly over the past 15 years. The
session will help guide practice decisions that integrate medical, nutritional, and behavioral
elements.
UPN: 069-000-08-105-L01-P
Back to
Overview |
T17
How to Actually MAKE Money Providing Diabetes Education
Gary Scheiner, MS, CDE
Owner/Director
Integrated Diabetes Services; Wynnewood, PA
If you're looking to turn your diabetes program from a loss leader into a PROFIT maker, this
session is not to be missed! Learn to tap into new revenue streams and hear dozens of ways to save
on operating and marketing costs.
UPN: 069-000-08-167-L04-P
Back to
Overview
|
T18
Dietary Supplements for Diabetes: The Intriguing Intricacies
Laura Shane-McWhorter, PharmD, BCPS, BC-ADM, CDE
Professor (Clinical)
University of Utah; Salt Lake City, UT
Dietary supplements are often attractive options for persons with diabetes. The diabetes
educator at all levels from basic to advanced practice, will benefit from learning more about the
pharmacology of the popular dietary supplements being used today.
UPN: 069-000-08-054-L01-P
Back to
Overview
|
T19
AADE Diabetes Education Delivery Model
Donna Rice, MBA, BSN, RN, CDE
Immediate Past President
AADE, Botsford Center for Health Improvement; Brighton, MI
Amparo Gonzalez, RN, BSN, CDE
President
AADE, Georgia Latino Diabetes Education Program; Atlanta, GA
We cannot do business as we did in the past! More than 85% of diabetes is treated in primary
care settings, yet diabetes educators are invisible in these arenas. Join us for this presentation
as we address alternative sites of care delivery and an expanded role and future for educators.
UPN: 069-000-08-101-L01-P
Back to
Overview
|
T20
CKD and Diabetes: Making a Difference
Joni J. Pagenkemper, MS, MA, RD, LMNT
Research Dietitian/Diabetes Coordinator
Creighton University Medical Center; Omaha, NE
A growing body of evidence suggests that some of the adverse outcomes of diabetes mellitus
(DM) and chronic kidney disease (CKD) can be avoided or delayed by preventive measures, early
detection and treatment.
UPN: 069-000-08-143-L01-P
Back to
Overview
|
T22
Optimizing the Value of Self-Monitoring of Blood Glucose
Barry H. Ginsberg, MD
Consultant
Diabetes Technology Consultants; Wyckoff, NJ
Self-monitoring of blood glucose is a prominent feature of modern diabetes therapy. The data
is important for care, yet is often inaccurate and almost always underutilized in decision-making.
This presentation will cover the sources of the errors in self-monitoring.
UPN: 069-000-08-104-L01-P
Back to
Overview
|
T23
Implementation of the Diabetes Prevention Program in Underserved Rural Settings
Melanie Moses-Stanley, MEd, RN, BSN, CDE, Retired US Navy Nurse Corps
Certified Diabetes Educator
Page Memorial Hospital; Luray, VA
Ann Hardinger, MS, RN
Staff Educator and Risk Manager
Page Memorial Hospital; Luray, VA
Sharon Clark, MS, RD, Dietetic Internship, BS, Home Economics, Nutrition Minor
Consultant Clinical Dietitian
North Mountain Dietetic Services, LLC; Mt. Jackson, VA
Learn how, despite limited resources and personnel, small rural hospitals can provide
successful diabetes prevention programs and impact the current diabetes epidemic in this country.
UPN: 069-000-08-082-L04-P
Back to
Overview
|
Concurrent Breakout Sessions 1:30 pm – 3:00 pm
|
T21
Minding Your Own Business: Private Practice for Diabetes Educators
Virginia K. Zamudio-Lange, RN, MSN, CDE
Partner
Alamo Diabetes Team, LLP; San Antonio, TX
Is running your own diabetes education business right for you? Find out more in this
session, which covers the fundamentals of operating a private practice. Learn about the
realities of self-employment and the basic how-tos of contracting.
UPN: 069-000-08-137-L03-P
Back to
Overview
|
T25
The Use of Oral Agents for Diabetics During Pregnancy
Edward J. Coetzee, MD, FRCOG, FCOG (SA)
Professor
Groote Schuur Hospital/University of Cape Town; Groote Schuur, South Africa
Lois Jovanović, MD, FACE
CEO & Chief Scientific Officer
Sansum Diabetes Research Institute; Santa Barbara, CA
Evaluating and educating women of child-bearing age with type 2 diabetes is a significant new
role for the diabetes educator. There has been resistance to the use of oral agents for diabetes
during pregnancy, but new evidence is emerging that glyburide and metformin are safe and easier to
use in gestational diabetes. In poorly-resourced countries, these oral agents are also much cheaper
than insulin. Hear these two international experts, Dr. Coetzee, the “father” of oral agents in
pregnancy, and Dr. Jovanović, as they continue their great debate at the recent IDF World Congress
in South Africa, on this emerging issue that’s impacting diabetes educators everywhere.
UPN: 069-000-08-091-L01-P
Back to
Overview
|
T26
Getting Started with Medication Management
Nancy J. D'Hondt, RPh, CDE
Clinical Pharmacist
St John Hospital; Detroit, MI
This session is designed to help the novice educator navigate the maze of medications
available to treat hyperglycemia. The presentation will review basic pathophysiology and
discuss the available treatment options utilized to manage patients with diabetes.
UPN: 069-000-08-133-L01-P
Back to
Overview
|
T27
Glycemic Management in Acute Care: Evidence, Practice, and Standards
Carol Manchester. MSN, APRN, BC-ADM, CDE
Diabetes Clinical Nurse Specialist
University of Minnesota Medical Center, Fairview; Minneapolis, MN
Nationwide, diabetes educators and advanced practitioners are being called upon by hospital
leaders to implement tight glycemic control programs. Yet, the evidence is still being gathered,
research conducted, and resources limited. This presentation will provide the latest research
findings, standards of practice, and useful strategies for the acute care professional.
UPN: 069-000-08-159-L01-P
Back to
Overview
|
T28a, T28b, T28c
Dealing with Specific Populations within the Diabetes Realm
Note: Must attend all sessions within section to recieve full credit.
T28a
Goals and Priorities of Men with Type 2 Diabetes
Marjorie Cypress, MSN, RN, APRN, CDE
Nurse Practitioner
University of New Mexico; Albuquerque, NM
Few studies focus primarily on men with type 2 diabetes in the community. This study explored
the goal priorities in men with type 2 diabetes by asking 140 men, both Hispanic and non Hispanic
to list their 3 most important goals. Results of the study and implications will be presented.
T28b
Comparing Quality of American Indian/Alaska Native Diabetes Education Programs
Yvette D. Roubideaux, MPH, MD
Assistant Professor, College of Medicine
The University of Arizona; Tucson, AZ
Tammy L. Brown, RD, MPH, BC-ADM, CDE
Nutrition Consultant, Division of Diabetes Treatment and Prevention
Indian Health Service; Albuquerque, NM
This presentation is geared towards diabetes educators interested in outcomes of diabetes
education and the impact of the level of services. Diabetes educators working with underserved
populations will find this work especially relevant.
T28c
Exploratory Research Examining Illness Narratives among African-American Diabetic Men
Leonard Jack, Jr., PhD, MS, BS
Professor
LSU Health Science Center School of Public Health; New Orleans, LA
Leandris Liburd, PhD, MPH
Branch Chief
Centers for Disease Control and Prevention; Atlanta, GA
Research exploring diabetes self-management among men is very limited. This is particularly
true for African-American men. Presenters of this session have conducted exploratory research to
identify psychosocial and behavioral perspectives of managing diabetes among African-American men.
UPN: 069-000-08-073-L04-P
Back to
Overview
|
T29
The JDRF Artificial Pancreas Project - CGM and Beyond
Aaron Kowalski, PhD
Program Director, Metabolic Control
Research Director, JDRF Artificial Pancreas Project
Juvenile Diabetes Research Foundation
Laurel Messer RN, BSN, CDE
Barbara Davis Center for Childhood Diabetes
University of Colorado Health Sciences Center
Aurora, Colorado
Dr. Kowalski and Ms. Messer will provide an up to the minute view of the rapidly evolving
world of new diabetes technologies and provide attendees with the tools to understand how to best
use these new devices to help their patients achieve better diabetes outcomes.
UPN: 069-000-08-178-L01-P
Back to
Overview
|
T31
Diabetes Primary Prevention - From Research to Reality
Kris Ernst, BSN, RN, CDE
Public Health Advisor and Program Consultant
Centers for Disease Control and Prevention; Atlanta, GA
Patricia R. Daly, MSN, FNP
Health Systems Specialist
Massachusetts Department of Health; Boston, MA
Heather M. Devlin, MA
Evaluation Lead and Research Analyst
MN Department of Health; St. Paul, MN
Gary He, PhD
Epidemiology and Surveillance Lead
CA Department of Health Services; Sacramento, CA
The Diabetes Primary Prevention Initiative (DPPI), a collaboration between CDC, state
grantees, their community partners, and contractors offers a promising framework for Type 2
diabetes primary prevention that can impact diabetes prevalence and costs.
UPN: 069-000-08-122-L01-P
Back to
Overview
|
Training for Reviewers 3:00 pm – 5:00 pm
|
|
T24
Peer Review Processes: Develop and Apply Critical Thinking Skills to Conduct High Quality
Reviews
Suzanne Austin Boren, PhD, MHA
Chair, 2008 AADE Research Committee
University of Missouri
Dept. of Health Management & Informatics
Julienne Kirk, PharmD
Member, 2008 Research Committee
Associate Professor
Wake Forest University Family & Comm. Medicine
Terry Lumber, RN, CNS, MSN, CDE, BC-ADM
Chair, 2008 Professional Practice Committee
Director
Inova Diabetes Center
Linda Haas, PHC RN CDE
Member, Past-Chair 2008 Professional Practice Committee
Endocrinology Clinical Nurse Specialist
VA Puget Sound Hcs Seattle Division/Prim
Terry Compton, MS APRN RN CDE
Member, 2008 Professional Practice Committee
Diabetes Nurse Coordinator
Southeastern Louisiana Univ. 10835
School of Nursing
Are you interested in being more effective in reviewing abstracts? Would you like to be more
confident in your ability to identify the extent to which materials developed by your peers are
relevant and accurate? Participating in this interactive program will enable you to critically
analyze documents and proposals and increase your confidence in participating in peer review
processes.
UPN# 069-000-08-175-L04-P
Back to
Overview
|
Corporate Symposia Sessions 4:15 pm – 5:45 pm
|
|
CS01
Home Continuous Glucose Monitoring: A New Perspective on Pathophysiology and
Treatment
Howard A. Wolpert, MD
Senior Physician and Director of the Insulin Pump Program
Joslin Diabetes Center; Boston, MA
Stacey O'Donnell, RN, BS, CDE
Nurse/Nurse Manager,
Joslin Diabetes Center; Boston, MA
Diana Stuber, MA, RD, CDE
Nutrition Educator/Insulin Pump Trainer
Joslin Diabetes Center at Upstate Medical University; Syracuse, NY
This symposium will discuss how assessing glycose patterns using continuous glucose
monitoring technology can inform the design and titration of insulin treatment programs that are
tailored to indvidual pathophysiology and lifestyle. Technical and educational issues will be
addressed to facilitate patient training in the use of this technology (e.g., alarm settings,
implications of lag on sensor calibration, interpreting glucose trends, and dose stacking) and
empower patients to take a more active role in self-care.
This program is supported by an educational grant provided by DexCom Inc.
Back to
Overview
|
|
CS03
Multidisciplinary Strategies in T2DM: A Critical Update on Performance Improvement &
Excellence in Care
Edward Horton, MD (Moderator)
Vice President and Director of Clinical Research
Joslin Diabetes Center; Boston, MA
Mary Ann Banerji, MD, FACP
Professor of Medicine
Director, Diabetes Treatment Center
SUNY Downstate Medical Center; Brooklyn, NY
Susan Cornell, BS, PharmD, CDE, BC-ADM
Assistant Professor of Pharmacy
Midwestern University, Chicago College of Pharmacy; Orland Park, IL
Geralyn R. Spollett , MSN, ANP, CDE
Associate Director, Yale Diabetes Center
Section of Endocrinology
Department of Internal Medicine
Yale University School of Medicine; New Haven CT
This program will examine the current and evolving treatment strategies for type 2 diabetes
through presentation and discussion of recent evidence. We will evaluate the new measurement
standards for Hemoglobin A1C and the application to the quality of care. Additionally, the
role of clinical performance measures and patient compliance will be discussed and their impact on
therapeutic outcomes. The program will utilize a case to apply the key concepts and create an
understanding of clinical effectiveness and its impact on quality of care in type 2 diabetes.
This program is supported by an educational grant provided by Merck & Co.,
Inc.
Back to
Overview
|
CS04
Balancing Insulin and Amylin for Optimal Pleiotropic Benefits in Diabetes
Management
Davida F. Kruger, MSN, APRN-BC, BC-ADM
Chairperson
Certified Nurse Practitioner
Division of Endocrinology and Metabolism
Henry Ford Medical Center
Detroit, Michigan
Stephen L. Aronoff, MD
Clinical Associate Professor of Medicine
University of Texas Southwestern
Medical School
Dallas, Texas
Harold E. Lebovitz, MD
Professor of Medicine
Division of Endocrinology
State University of New York Health Science
Center at Brooklyn
Brooklyn, New York
This symposium will explore Amylin replacement with pramlintide in a multi-hormonal approach
to glucoregulation, the rationale underlying the use of these therapies, and the implications of
this therapeutic option in the achievement of treatment goals in diabetes management. This
interactive presentation will include use of patient video of case-based studies, an audience
response system and a panel question and answer session.
This program is supported by an educational grant provided by Amylin.
Back to
Overview |
CS05
New Approaches to Old Challenges: Discovering the Role of Insulin Analogs and Incretin
Mimetics
Richard E. Pratley, MD
Professor of Medicine
University of Vermont College of Medicine; South Burlington, VT
Martha Funnell, MS, RN, CDE
Director of Administration
University of Michigan Medical School; Ann Arbor, MI
Virginia Peragallo-Dittko, RN, BC-ADM, MA, CDE
Director, Diabetes Education Center
Winthrop-University Hospital; Mineloa, NY
The potentially devasting consequences of uncontrolled diabetes underscore the need to treat
with the most effective agents for maintaining glycemic control. This symposium will evalute
treatment options, explain the biologic effects of incretin hormones as well as increatin mimetics
and DPP-4 inhibitors, discuss the rationale for selecting incretin or insulin therapy in patients
with type 2 diabetes, and integrate safety and efficacy data from recent clinical trials in the
development and implementation of treatment plans appropriate to patients' diabetes and lifestyle.
This program is supported by an eduational grant provided by Novo Nordisk.
Back to
Overview |
|
CS09
Men’s Health: The Relationship Between Disease, Diabetes and Low Testosterone
Shari Fine, D.O., FACOFP
Director, FP Residency Program
Christ Hospital
Short Hills, NY
Donna Rice, MBA, BSN,CDE
Wellness Program Manager, Consultant
Botsford Center for Lifestyle Management
Brighton, MI
Keith Campbell RPh, CDE, MBA, FASHP
Distinguished Professor
J. Roberts & Marcia Fosberg Distinguished Professor of Pharmacy
Certified Diabetes Educator
Washington State University College Pharmacy
Pullman, WA
Leonard Jack, Jr. PhD, MSc
Jim Finks Endowed Chair of Health Promotion
Professor
Behavioral and Community Health Sciences
School of Public Health
Louisiana State University
New Orleans, LA
This symposium will examine the relationship between men’s health, diabetes, and low
testosterone. The development and relationship of male hypogonadism to diabetes will be explored.
Discussion of signs, symptoms and treatment options will help to identify patients at risk for
developing hypogonadism. Through problem based learning and interactive discussion the diabetes
educator will enhance their knowledge of treatment options and goals for testosterone replacement
therapies of this often undiagnosed disease.
This program is supported by an educational grant provided by Solvay Pharmaceuticals.
Back to
Overview
|
